← Leaderboards
Michael B Oldstone
Scripps Research Institute
$35,619,947
Attributed
$35,619,947
Total exposure
21
Grants
9
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $5.2M · FY2005–16$10M$7.5M$5M$2.5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
Funding mix
By agency
NIH$48,481,346 · 22
By mechanism
R01$22,500,494 · 11
P01$16,171,865 · 6
U01$8,108,774 · 1
U54$686,519 · 1
T32$529,444 · 1
R21$469,250 · 1
Top collaborators
No co-investigators on record.
Most similar at Scripps Research Institute
Same institution · by research overlap
- Howard S. Fox$60,934,349
- Dennis R. Burton$354,198,604
- Erica Ollmann Saphire$52,684,297
- John Johnson$22,284,193
- Juan C. De La Torre$34,810,527
Others in their field
Top investigators on “Lymphocytic Choriomeningitis Virus”
- Arlene H Sharpe · Harvard Medical School$19,979,288
- Elina I Zuniga · University Of California, San Diego$18,963,351
- E. John Wherry · Emory University$18,691,932
- Juan C. De La Torre · Scripps Research Institute$15,721,174
- Rama Rao Amara · Emory University$15,655,138
- J. Lindsay Whitton · Scripps Research Institute$11,715,760
Research focus
Lymphocytic Choriomeningitis VirusLaboratory MouseVirus DiseasesIn VivoImmune ResponseVirusViralInfectionCellsGenetically Modified AnimalsVirus ReceptorsT-LymphocytePreventMediatingDisease /Disorder ModelDesignAntiviral AgentsImmunopathologyImmune SystemReceptorMolecularResponseGrantRecombinants
Grant awards (104)
Host Genetic Factors to Combat Lassa Hemorrhagic Fever$481,250
R01 · FY2016 · AI · contact PI
Pathogenesis of Persistent Viral Infection$481,250
R01 · FY2016 · AI · contact PI
Host Genetic Factors to Combat Lassa Hemorrhagic Fever$473,750
R01 · FY2015 · AI · contact PI
Pathogenesis of Persistent Viral Infection$473,750
R01 · FY2015 · AI · contact PI
Pathogenesis of Persistent Viral Infection$473,750
R01 · FY2014 · AI · contact PI
Host Genetic Factors to Combat Lassa Hemorrhagic Fever$473,750
R01 · FY2014 · AI · contact PI
Host Genetic Factors to Combat Lassa Hemorrhagic Fever$445,325
R01 · FY2013 · AI · contact PI
Pathogenesis of Persistent Viral Infection$445,325
R01 · FY2013 · AI · contact PI
Pathogenesis of Acute Respiratory Diseases: SARS and INFLUENZA$361,789
U54 · FY2013 · AI · contact PI
Pathogenesis of Persistent Viral Infection$464,322
R01 · FY2012 · AI · contact PI
Pathogenesis of Acute Respiratory Diseases: SARS and INFLUENZA$324,730
U54 · FY2012 · AI · contact PI
Novel Chemical and Immunological Approaches to Influenza Therapy$1,635,674
U01 · FY2011 · AI · contact PI
Pathogenesis of Persistent Viral Infection$464,322
R01 · FY2011 · AI · contact PI
In Vivo Analysis of T lymphocytes in the Persistently Infected CNS$455,501
R01 · FY2011 · AI · contact PI
Novel Chemical and Immunological Approaches to Influenza Therapy$1,655,651
U01 · FY2010 · AI · contact PI
Therapeutics to Prevent/Treat Lassa Fever Virus$474,750
R01 · FY2010 · AI · contact PI
Pathogenesis of Persistent Viral Infection$469,013
R01 · FY2010 · AI · contact PI
In Vivo Analysis of T lymphocytes in the Persistently Infected CNS$460,102
R01 · FY2010 · AI · contact PI
Arenavirus Receptor-Structure/Function Studies$402,083
R01 · FY2010 · AI · contact PI
Novel Chemical and Immunological Approaches to Influenza Therapy$1,627,220
U01 · FY2009 · AI · contact PI
Therapeutics to Prevent/Treat Lassa Fever Virus$474,750
R01 · FY2009 · AI · contact PI
Pathogenesis of Persistent Viral Infection$473,750
R01 · FY2009 · AI · contact PI
In Vivo Analysis of T lymphocytes in the Persistently Infected CNS$464,749
R01 · FY2009 · AI · contact PI
Arenavirus Receptor-Structure/Function Studies$406,144
R01 · FY2009 · AI · contact PI
Novel Chemical and Immunological Approaches to Influenza Therapy$1,583,376
U01 · FY2008 · AI · contact PI
Aging Disease--Prion/Transgenic/Immunologic Studies$1,494,933
P01 · FY2008 · AG · contact PI
Pathogenesis of Persistent Viral Infection$473,750
R01 · FY2008 · AI · contact PI
Therapeutics to Prevent/Treat Lassa Fever Virus$440,665
R01 · FY2008 · AI · contact PI
Arenavirus Receptor-Structure/Function Studies$398,428
R01 · FY2008 · AI · contact PI
Transgenic models of transmissible spongiform encephalopathy$373,733
P01 · FY2008 · AG · contact PI
Novel Chemical and Immunological Approaches to Influenza Therapy$1,606,853
U01 · FY2007 · AI · contact PI
Aging Disease--Prion/Transgenic/Immunologic Studies$1,566,067
P01 · FY2007 · AG · contact PI
Therapeutics to Prevent/Treat Lassa Fever Virus$444,933
R01 · FY2007 · AI · contact PI
Arenavirus Receptor--Structure/Function Studies$406,145
R01 · FY2007 · AI · contact PI
Pathogenesis of Persistent Viral Infection$400,441
R01 · FY2007 · AI · contact PI
Transgenic models of transmissible spongiform encephalopathy$391,516
P01 · FY2007 · AG · contact PI
Measles Virus Studies in a Transgenic Model$351,206
R01 · FY2007 · AI · contact PI
Aging Disease--Prion/Transgenic/Immunologic Studies$1,572,510
P01 · FY2006 · AG · contact PI
Therapeutics to Prevent/Treat Lassa Fever Virus$458,223
R01 · FY2006 · AI · contact PI
Arenavirus Receptor-Structure/Function Studies$418,275
R01 · FY2006 · AI · contact PI
Pathogenesis of Persistent Viral Infection$412,401
R01 · FY2006 · AI · contact PI
Measles Virus Studies in a Transgenic Model$361,696
R01 · FY2006 · AI · contact PI
Transgenic models of transmissible spongiform encephalop$166,550
P01 · FY2006 · AG · contact PI
Aging Disease--Prion/Transgenic/Immunologic Studies$1,535,853
P01 · FY2005 · AG
Therapeutics to Prevent/Treat Lassa Fever Virus$469,250
R01 · FY2005 · AI
Pathogenesis of Persistent Viral Infection$452,850
R01 · FY2005 · AI
Measles Virus Studies in a Transgenic Model$370,400
R01 · FY2005 · AI
Viruses and Diabetes$287,062
R01 · FY2005 · DK
Transgenic models of transmissible spongiform encephalop$166,550
P01 · FY2005 · AG
Aging Disease--Prion/Transgenic/Immunologic Studies$100,663
P01 · FY2005 · AG
Aging Disease--Prion/Transgenic/Immunologic Studies$1,503,420
P01 · FY2004 · AG
Pathogenesis of Persistent Viral Infection$437,678
R01 · FY2004 · AI
Measles Virus Studies in a Transgenic Model$370,400
R01 · FY2004 · AI
Therapeutics to Prevent/Treat Lassa Fever Virus$312,834
R01 · FY2004 · AI
ARENAVIRUS RECEPTOR--STRUCTURE/FUNCTION STUDIES$310,275
R01 · FY2004 · AI
Viruses and Diabetes$287,062
R01 · FY2004 · DK
ADMINISTRATIVE CORE$166,550
P01 · FY2004 · AG
Transgenic models of transmissible spongiform encephalop$166,550
P01 · FY2004 · AG
AGING DISEASE--TRANSGENIC/VIROLOGIC/IMMUNOLOGIC STUDIES$1,289,807
P01 · FY2003 · AG
Therapeutics to Prevent/Treat Lassa Fever Virus$469,250
R21 · FY2003 · AI
Measles Virus Studies in a Transgenic Model$370,400
R01 · FY2003 · AI
Pathogenesis Studies in Scrapie (TSE Diseases)$347,245
R01 · FY2003 · NS
ARENAVIRUS RECEPTOR--STRUCTURE/FUNCTION STUDIES$310,275
R01 · FY2003 · AI
Viruses and Diabetes$287,062
R01 · FY2003 · DK
Pathogenesis of Persistent Viral Infection$251,408
R01 · FY2003 · AI
AGING DISEASE--TRANSGENIC/VIROLOGIC/IMMUNOLOGIC STUDIES$1,255,043
P01 · FY2002 · AG
Viruses and Diabetes$353,732
R01 · FY2002 · DK
PATHOGENESIS OF PERSISTENT VIRAL INFECTION$342,676
R01 · FY2002 · AI
ARENAVIRUS RECEPTOR--STRUCTURE/FUNCTION STUDIES$310,275
R01 · FY2002 · AI
MEASLES VIRUS STUDIES IN A TRANSGENIC MODEL$270,834
R01 · FY2002 · AI
NEUROBIOLOGIC AND IMMUNOLOGIC ASPECTS OF AGING$196,055
T32 · FY2002 · AG
CORE--TRANSGENIC$178,517
P01 · FY2002 · AG
CORE--TISSUE CULTURE$178,517
P01 · FY2002 · AG
AGING DISEASE--TRANSGENIC/VIROLOGIC/IMMUNOLOGIC STUDIES$178,517
P01 · FY2002 · AG
AGING DISEASE--TRANSGENIC/VIROLOGIC/IMMUNOLOGIC STUDIES$1,048,805
P01 · FY2001 · AG
PATHOGENESIS OF PERSISTENT VIRAL INFECTION$334,789
R01 · FY2001 · AI
ARENAVIRUS RECEPTOR--STRUCTURE/FUNCTION STUDIES$310,275
R01 · FY2001 · AI
NEUROBIOLOGIC AND IMMUNOLOGIC ASPECTS OF AGING$302,319
T32 · FY2001 · AG
STUDIES OF A NEW MYELIN GENE THAT CAUSES CNS DISEASE$290,042
R01 · FY2001 · NS
MEASLES VIRUS STUDIES IN A TRANSGENIC MODEL$264,139
R01 · FY2001 · AI
VIRUSES AND AUTOIMMUNE DISEASE$224,523
R01 · FY2001 · AI
CORE--TRANSGENIC$149,274
P01 · FY2001 · AG
CORE--TISSUE CULTURE$149,274
P01 · FY2001 · AG
AGING DISEASE--TRANSGENIC/VIROLOGIC/IMMUNOLOGIC STUDIES$149,274
P01 · FY2001 · AG
AGING DISEASE: TRANSGENIC/VIROLOGIC/IMMUNOLOGIC STUDIES$123,004
P01 · FY2001 · AG
CORE--TRANSGENIC$0
P01 · FY2001 · AG
AGING DISEASE--TRANSGENIC/VIROLOGIC/IMMUNOLOGIC STUDIES$0
P01 · FY2001 · AG
CORE--TISSUE CULTURE$0
P01 · FY2001 · AG
AGING DISEASE--TRANSGENIC/VIROLOGIC/IMMUNOLOGIC STUDIES$1,225,454
P01 · FY2000 · AG
PATHOGENESIS OF PERSISTENT VIRAL INFECTION$332,689
R01 · FY2000 · AI
ARENAVIRUS RECEPTOR--STRUCTURE/FUNCTION STUDIES$310,275
R01 · FY2000 · AI
STUDIES OF A NEW MYELIN GENE THAT CAUSES CNS DISEASE$281,607
R01 · FY2000 · NS
MEASLES VIRUS STUDIES IN A TRANSGENIC MODEL$257,638
R01 · FY2000 · AI
VIRUSES AND AUTOIMMUNE DISEASE$220,213
R01 · FY2000 · AI
ANATOMY OF MEASLES VIRUS/RECEPTOR INTERACTION$208,787
R01 · FY2000 · AI
CORE--TISSUE CULTURE$149,274
P01 · FY2000 · AG
AGING DISEASE--TRANSGENIC/VIROLOGIC/IMMUNOLOGIC STUDIES$149,274
P01 · FY2000 · AG
CORE--TRANSGENIC$149,274
P01 · FY2000 · AG
CORE--TRANSGENIC$149,274
P01 · FY2000 · AG
CORE--TISSUE CULTURE$149,274
P01 · FY2000 · AG
AGING DISEASE--TRANSGENIC/VIROLOGIC/IMMUNOLOGIC STUDIES$149,274
P01 · FY2000 · AG
AGING DISEASE--TRANSGENIC/VIROLOGIC/IMMUNOLOGIC STUDIES$145,840
P01 · FY2000 · AG
NEUROBIOLOGIC AND IMMUNOLOGIC ASPECTS OF AGING$31,070
T32 · FY2000 · AG
CELL BIOLOGY OF VIRUS ENTRY, REPLICATION AND PATHOGENESI$15,000
R13 · FY2000 · CA